Spontaneous Urticaria

• CLINICAL_TRIALS trial_result · 2021-04-28
  Clinical Trial Update: Tranexamic Acid and Spontaneous Chronic Urticaria [Phase 4]

  Phase 4 trial update involving tranexamic acid for chronic spontaneous urticaria.

• CLINICAL_TRIALS trial_result · 2020-11-04
  Clinical Trial Update: Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria [Phase 3]

  Phase 3 trial evaluating efficacy and safety of Xolair (omalizumab) in Chinese patients with chronic spontaneous urticaria has completed wit…

• CLINICAL_TRIALS trial_result · 2020-09-29
  Clinical Trial Update: A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU). [Phase 2]

  Phase 2 trial update for GDC-0853 in refractory chronic spontaneous urticaria (CSU) has completed with results posted.

• CLINICAL_TRIALS trial_result · 2020-09-09
  Clinical Trial Update: Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy [Phase 3]

  Phase 3 trial assessing omalizumab's impact on quality of life and angioedema frequency in patients with chronic spontaneous urticaria refra…

• CLINICAL_TRIALS trial_result · 2020-08-14
  Clinical Trial Update: A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients [Phase 2]

  Phase 2 safety extension study assessing long-term safety of QGE031 (ligelizumab) in chronic spontaneous urticaria; completed with results p…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-02-25
  Clinical Trial Update: Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment [Phase 4]

  Phase 4 study updating on omalizumab in chronic spontaneous urticaria patients not responding to initial antihistamine treatment; results po…

• CLINICAL_TRIALS trial_result · 2018-09-18
  Clinical Trial Update: Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria [Phase 3]

  Phase 3 trial evaluating fourfold dosage of levocetirizine for chronic spontaneous urticaria has completed.

• CLINICAL_TRIALS trial_result · 2018-09-14
  Clinical Trial Update: Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU [Phase 2]

  Phase 2 dose-finding trial of QGE031 as add-on therapy for chronic spontaneous urticaria has completed with results posted.

• CLINICAL_TRIALS trial_result · 2018-08-08
  Clinical Trial Update: OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients [Phase 3]

  Phase 3 trial updates on re-treatment and step-up therapy with omalizumab for chronic spontaneous urticaria (CSU) completed with posted resu…

• CLINICAL_TRIALS trial_result · 2018-03-26
  Clinical Trial Update: A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria [Phase 4]

  This Phase 4 trial update reports the efficacy and safety of omalizumab through 48 weeks in participants with chronic spontaneous urticaria.

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria [Phase 2]

  This document reports the completion of a Phase 2 randomized trial comparing quilizumab to placebo in patients with refractory chronic spont…

• CLINICAL_TRIALS trial_result · 2016-09-20
  Clinical Trial Update: Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria Patients [Phase 3]

  A Phase 3 trial evaluating the efficacy and safety of omalizumab in patients with refractory chronic spontaneous urticaria has completed, wi…

• CLINICAL_TRIALS trial_result · 2016-08-26
  Clinical Trial Update: Bilastine Updosing in Chronic Spontaneous Urticaria [Phase 3]

  Phase 3 trial update on bilastine dosing for chronic spontaneous urticaria; the study has completed.

• CLINICAL_TRIALS trial_result · 2016-08-19
  Clinical Trial Update: High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria [Phase 3]

  An update on a Phase 3 trial evaluating high-dose vitamin D supplementation for chronic spontaneous urticaria, sponsored by Shiraz Universit…

• CLINICAL_TRIALS trial_result · 2014-04-15
  Clinical Trial Update: Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients [Phase 2, Phase 3]

  Prospective double-blind, placebo-controlled trial of omalizumab (Xolair) in chronic urticaria, spanning Phase 2 and Phase 3 cohorts.

• CLINICAL_TRIALS trial_result · 2013-10-18
  Clinical Trial Update: A Study of the Efficacy and Safety of Omalizumab (Xolair) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine (H1) Treatment [Phase 3]

  A Phase 3 trial evaluating the efficacy and safety of omalizumab (Xolair) in chronic idiopathic urticaria and chronic spontaneous urticaria …

• CLINICAL_TRIALS trial_result · 2013-09-02
  Clinical Trial Update: A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1) [Phase 3]

  Phase 3 trial evaluating the efficacy, duration of response, and safety of Xolair (omalizumab) in patients with chronic idiopathic urticaria…